These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver. Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402 [TBL] [Abstract][Full Text] [Related]
26. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115 [TBL] [Abstract][Full Text] [Related]
27. Role of spleen in hepatic ischemia reperfusion injury: Splenic congestion during ischemia accelerates leukocyte infiltration within the liver after reperfusion. Kato H; Hamada T; Kuriyama N; Ito T; Magawa S; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S Hepatol Res; 2017 Mar; 47(3):E132-E141. PubMed ID: 27153152 [TBL] [Abstract][Full Text] [Related]